News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Geron Corporation abandons stem cell research

By Stephanie O'Neill, KPCC Southern California Public Radio | 11.16.2011
Stem cell therapies may one day provide cures for spinal chord injuries, heart damage and other serious medical conditions. For...
Fact Sheets

Geron Corporation abandons stem cell research

By Stephanie O'Neill, KPCC Southern California Public Radio | 11.16.2011
Stem cell therapies may one day provide cures for spinal chord injuries, heart damage and other serious medical conditions. For...
Fact Sheets

Ruling Restricts Newborn Blood Use

By Tony Kennedy, Star Tribune | 11.16.2011
The two-year-old case has pitted the genetic-privacy rights of families against science designed to advance public health and has put...
Genomics

Ruling Restricts Newborn Blood Use

By Tony Kennedy, Star Tribune | 11.16.2011
The two-year-old case has pitted the genetic-privacy rights of families against science designed to advance public health and has put...
Genomics

Without Consent: How Drug Companies Exploit Indian 'Guinea Pigs'

By Andrew Buncombe and Nina Lakhani, The Independent UK | 11.14.2011
Western pharmaceutical companies have seized on India over the past five years as a testing ground for drugs – making...
Biotech & Pharma

Without Consent: How Drug Companies Exploit Indian 'Guinea Pigs'

By Andrew Buncombe and Nina Lakhani, The Independent UK | 11.14.2011
Western pharmaceutical companies have seized on India over the past five years as a testing ground for drugs – making...
Biotech & Pharma

First Test of Human Embryonic Stem Cell Therapy in People Discontinued

By Rob Stein, The Washington Post | 11.14.2011
The company conducting the first government-approved tests in people of a therapy developed using human embryonic stem cells abruptly announced...
Stem Cells

First Test of Human Embryonic Stem Cell Therapy in People Discontinued

By Rob Stein, The Washington Post | 11.14.2011
The company conducting the first government-approved tests in people of a therapy developed using human embryonic stem cells abruptly announced...
Stem Cells